Best for 0% commission stocks
Capital at risk. T&Cs apply.
Copy picks from top traders
Commission-free trades
Fractional shares
Get dividend payments
Fractional shares
Get dividend payments
Aurora Cannabis Inc (ACB) is a publicly traded drug manufacturers - specialty and generic business based in Canada which employs around 1,050 staff. Aurora Cannabis is listed on the NASDAQ and traded in US dollars. Its current price of $4.61 is 14.8% up on its price a month ago ($4.02).
How to buy shares in Aurora Cannabis
- Open a brokerage account. Choose from our top broker picks or compare brokers in depth. Then, complete an application.
- Fund your account. Add money to your account via bank transfer, debit card or credit card.
- Search the platform by ticker symbol. ACB in this case.
- Choose an order type. Place a market order or limit order with your preferred number of shares or dollar amount.
- Submit the order. It's that simple.
Our top picks for where to buy Aurora Cannabis shares
Best for international trading
Capital at risk. T&Cs apply.
4.5% interest on uninvested cash
11,000+ stocks & ETFs
Commission-free investing
Advanced trading tools
Commission-free investing
Advanced trading tools
Best for fractional shares
Capital at risk. T&Cs apply.
Earn 4.5% on uninvested funds
Commission-free trades
Fractional shares
5,400+ stocks/ETFs
Fractional shares
5,400+ stocks/ETFs
Aurora Cannabis stock chart
Use our graph to track the performance of ACB stock over time.Fees calculator for buying Aurora Cannabis shares with popular apps
Find the cheapest way to buy Aurora Cannabis shares with our calculator. Bear in mind that both exchange rates and share prices fluctuate in real time, so the costs estimated here are just a guide (refer to platforms themselves for availability and exact pricing).
Quantity of shares
1000
| Platform | Finder Score | Account fee | Min. initial deposit | Trade cost | Link |
|---|---|---|---|---|---|
|
9
Excellent
|
£0 | $100 | £3,481.11 |
Go to siteCapital at risk
|
 |
9.1
Excellent
|
£0 | £0 | £3,489.40 |
Go to siteCapital at risk
|
|
9
Excellent
|
From £0 | £0 | £3,479.38 |
Go to siteCapital at risk
|
 |
8.8
Great
|
£0 | £0 | £3,456.23 |
Go to siteCapital at risk
|
|
9.2
Excellent
|
£0 | £0 | £3,472.47 |
Go to siteCapital at risk
|
 |
8.5
Great
|
£0 (0.45% for funds) | £1 | £3,501.70 |
Go to siteCapital at risk
|
Full comparison of share dealing platforms
These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Alternative ways to invest in Aurora Cannabis
Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including Aurora Cannabis), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.
Aurora Cannabis is a major part of the NASDAQ, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).
Is it a good time to buy Aurora Cannabis stock?
Review technicals and fundamentals to help you determine if now's a good time for you to invest.
Technical analysis
View Aurora Cannabis's price performance, share price volatility, historical data and technicals.
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
Historical closes compared with the last close of $4.72
| 1 week (2025-04-29) | 1.72% |
|---|---|
| 1 month (2025-04-06) | 17.56% |
| 3 months (2025-02-06) | -12.10% |
| 6 months (2024-11-06) | -7.27% |
| 1 year (2024-05-06) | -28.92% |
| 2 years (2023-05-06) | -28.05% |
| 3 years (2022-05-06) | -83.20% |
| 5 years (2020-05-06) |
Invest in Aurora Cannabis shares
Finder AwardFree Trades
- Over 5,500+ stocks from 20 exchanges
- Free to open an account
- Commission-free trading
Go to site
Capital at risk
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is Aurora Cannabis under- or over-valued?
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Aurora Cannabis P/E ratio, PEG ratio and EBITDA.
Aurora Cannabis's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Aurora Cannabis's shares trade at around 24x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of March 2025 (25.37). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Aurora Cannabis's P/E ratio is best considered in relation to those of others within the industry or those of similar companies.
- Aphria (APHA.US): 0.00
- Tilray (TLRY.US): 0.00
- OrganiGram (OGI.US): 0.00
- SNDL (SNDL.US): 0.00
Aurora Cannabis's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give None. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Aurora Cannabis's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
However, it's sensible to consider Aurora Cannabis's PEG ratio in relation to those of similar companies.
- Aphria (APHA.US): 0.00
- Tilray (TLRY.US): 0.00
- OrganiGram (OGI.US): 0.00
- SNDL (SNDL.US): 0.00
Aurora Cannabis's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $61.7 million (£46.4 million).
The EBITDA is a measure of Aurora Cannabis's overall financial performance and is widely used to measure a its profitability.
To put that into context you can compare it against similar companies.
- Aphria (APHA.US): USD$9 million
- Tilray (TLRY.US): USD$32 million
- OrganiGram (OGI.US): USD$-15039000
- SNDL (SNDL.US): USD$-9132000
Frequently asked questions
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Ready to compare platforms?More resources on Finder
More guides on Finder
-
Best care home stocks 2025
Find out the best care home shares along with the pros and cons of investing in this grey-pound-fuelled sector.
-
Mental health stocks: Popular mental health companies to invest in
Mental health stocks can be rewarding, but there are risks involved that could impact your profits. Find out how to invest in companies in the mental health industry.
-
Invest in pharmaceutical stocks
Pharma stocks can be rewarding, but there are risks involved that could impact your profits. Find out the best way to invest in pharma stock.
-
How to buy Curaleaf Holdings shares
Ever wondered how to buy shares in Curaleaf Holdings? We explain how and compare a range of providers that can give you access to many brands, including Curaleaf Holdings.
-
How to buy Eli Lilly and Company shares
Ever wondered how to buy shares in Eli Lilly and Company? We explain how to invest in Eli Lilly in the UK along with platforms for buying stock.
-
How to buy Walgreens Boots Alliance shares
Ever wondered how to buy shares in Walgreens? We explain how and compare a range of providers that can give you access to many brands, including Walgreens.
-
How to buy Medtronic shares
Ever wondered how to buy shares in Medtronic? We explain how and compare a range of providers that can give you access to many brands, including Medtronic.
-
How to buy AstraZeneca shares
Ever wondered how to buy shares in AstraZeneca? We explain how and compare a range of providers that can give you access to many brands, including AstraZeneca.
-
How to buy GSK shares
Learn more about GSK’s recent performance and where you can buy GSK shares. We also run through a helpful checklist for anyone looking to invest.